Dataset Information


HERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.

ABSTRACT: hERG1 channels are aberrantly expressed in human cancers. The expression, functional role and clinical significance of hERG1 channels in pancreatic ductal adenocarcinoma (PDAC) is lacking.hERG1 expression was tested in PDAC primary samples assembled as tissue microarray by immunohistochemistry using an anti-hERG1 monoclonal antibody (?-hERG1-MoAb). The functional role of hERG1 was studied in PDAC cell lines and primary cultures. ERG1 expression during PDAC progression was studied in Pdx-1-Cre,LSL-Kras(G12D/+),LSL-Trp53(R175H/+) transgenic (KPC) mice. ERG1 expression in vivo was determined by optical imaging using Alexa-680-labelled ?-hERG1-MoAb.(i) hERG1 was expressed at high levels in 59% of primary PDAC; (ii) hERG1 blockade decreased PDAC cell growth and migration; (iii) hERG1 was physically and functionally linked to the Epidermal Growth Factor-Receptor pathway; (iv) in transgenic mice, ERG1 was expressed in PanIN lesions, reaching high expression levels in PDAC; (v) PDAC patients whose primary tumour showed high hERG1 expression had a worse prognosis; (vi) the ?-hERG1-MoAb could detect PDAC in vivo.hERG1 regulates PDAC malignancy and its expression, once validated in a larger cohort also comprising of late-stage, non-surgically resected cases, may be exploited for diagnostic and prognostic purposes in PDAC either ex vivo or in vivo.

SUBMITTER: Lastraioli E 

PROVIDER: S-EPMC4366888 | BioStudies | 2015-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2008-01-01 | S-EPMC2519704 | BioStudies
2018-01-01 | S-EPMC6034270 | BioStudies
2010-01-01 | S-EPMC2952224 | BioStudies
2000-01-01 | S-EPMC1572425 | BioStudies
2014-01-01 | S-EPMC3971662 | BioStudies
2012-01-01 | S-EPMC3411645 | BioStudies
2010-01-01 | S-EPMC2835770 | BioStudies
2012-01-01 | S-EPMC3261411 | BioStudies
2016-01-01 | S-EPMC5034692 | BioStudies
2015-01-01 | S-EPMC4429717 | BioStudies